Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes

被引:0
|
作者
Yi Ren
Lei Chen
Ruochun Guo
Shiyang Ma
Shenghui Li
Yue Zhang
Hongli Jiang
Haitao Shi
Pan Zhang
机构
[1] the First Affiliated Hospital of Xi’an Jiaotong University,Department of Critical Care Nephrology and Blood Purification
[2] People’s Hospital of Longhua,Department of Nephrology
[3] The Second Affiliated Hospital of Xi’an Jiaotong University,Department of Gastroenterology
[4] Shaanxi Key Laboratory of Gastrointestinal Motility Disorders,undefined
[5] Shaanxi Provincial Clinical Research Center for Gastrointestinal Diseases,undefined
[6] Digestive Disease Quality Control Center of Shaanxi Province,undefined
[7] Puensum Genetech Institute,undefined
来源
Journal of Translational Medicine | / 22卷
关键词
End-stage renal disease; Gut mycobiome; Shotgun metagenome sequencing; Serum metabolome; Fecal metabolome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Why is troponin T increased in the serum of patients with end-stage renal disease?
    McNeil, AR
    Marshall, M
    Ellis, CJ
    Hawkins, RC
    CLINICAL CHEMISTRY, 1998, 44 (11) : 2377 - 2378
  • [32] Serum albumin fragmentation in end-stage renal disease patients - a pilot study
    Donadio, Elena
    Piccolomini, Francesco
    Dimuccio, Veronica
    Felicioli, Antonio
    Balestreri, Ettore
    Cianti, Riccardo
    Armini, Alessandro
    Bini, Luca
    Felicioli, Romano
    Donadio, Carlo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (11) : 1373 - 1379
  • [33] Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease
    Arabul, Mahnnut
    Gullulu, Mustafa
    Yilmaz, Yusuf
    Akdag, Ibrahim
    Kahvecioglu, Serdar
    Eren, Mehmet Ali
    Dilek, Kamil
    CLINICAL BIOCHEMISTRY, 2008, 41 (13) : 1055 - 1058
  • [34] Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease Reply
    Sehgal, Ashwini R.
    Sullivan, Catherine
    Sayre, Srilekha S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (23): : 2444 - 2444
  • [35] Significance of serum creatinine values in new end-stage renal disease patients
    Fink, JC
    Burdick, RA
    Kurth, SJ
    Blahut, SA
    Armistead, NC
    Turner, MS
    Shickle, LM
    Light, PD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : 694 - 701
  • [36] Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease
    Ashfaq, Akhtar
    Gitman, Michael
    Singhal, Pravin C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (14) : 1897 - 1905
  • [37] Serum sodium, renal function, and survival of patients with end-stage liver disease
    Lim, Young-Suk
    Larson, Timothy S.
    Benson, Joanne T.
    Kamath, Patrick S.
    Kremers, Walter K.
    Therneau, Terry M.
    Kim, W. Ray
    JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 523 - 528
  • [38] Accuracy of measured vancomycin serum concentrations in patients with end-stage renal disease
    Smith, PF
    Morse, GD
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1329 - 1335
  • [39] Gut Microbial Translocation in the Pathogenesis of Systemic Inflammation in Patients with End-Stage Renal Disease
    Nosratola D. Vaziri
    Digestive Diseases and Sciences, 2014, 59 : 2020 - 2022
  • [40] Gut Microbial Translocation in the Pathogenesis of Systemic Inflammation in Patients with End-Stage Renal Disease
    Vaziri, Nosratola D.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (09) : 2020 - 2022